|
ZA9204959B
|
|
Hydroisoquinoline derivatives
|
|
GB9211409D0
|
|
Imidazopiperidine derivatives
|
|
WO9220657A1
|
|
2-(pyrrolidinyl-1-methyl)-piperidine derivatives and their use as kappa-recept or agonists
|
|
GB9209224D0
|
|
Novel compounds
|
|
WO9218115A1
|
|
Use of heterocyclic compounds for the treatment of inflammatory pain
|
|
ITMI920563D0
|
|
Hydroisoquinoline derivatives
|
|
GB9202934D0
|
|
Imidazopiperidine derivatives
|
|
ITMI912798D0
|
|
Diazacyclic derivatives
|
|
GB9115143D0
|
|
Novel use
|
|
GB9114106D0
|
|
Novel compounds
|
|
GB9111709D0
|
|
Imidazopiperidine derivatives
|
|
GB9111684D0
|
|
Imidazopiperidine derivatives
|
|
GB9110951D0
|
|
Azacyclic derivatives
|
|
GB9110989D0
|
|
Azacyclic derivatives
|
|
PT97430A
|
|
Process for the preparation of pyrroline derivatives
|
|
GB9108326D0
|
|
Novel use
|
|
GB9108128D0
|
|
Novel formulation
|
|
EP0594611A1
|
|
Novel 1-(2h-1-oxo-3,4-dihydronaphtyl-6)-acetyl-piperidines, process for their preparation and therapeutic use
|
|
ZA9102744B
|
|
Pharmaceuticals
|
|
IE911170A1
|
|
Pharmaceuticals
|
